Abbreviations: sAVR, surgical aortic valve replacement; TA, transapical; TAVI, transcatheter aortic valve implantation; TF, transfemoral.

During the 30-day postoperative phase, patients were at risk of operative death and postoperative complications, including stroke, myocardial infarction, acute kidney injury, other acute complications (endocarditis, major vascular complications, pacemaker implantation, paravalvular leaks, major bleeding and atrial fibrillation), and reoperation. Patients in the TF TAVI and TF/TA TAVI arms were also at risk of conversion to sAVR.